Dashenlin Pharmaceutical Group Co., Ltd. (603233)
Market Open
10 Aug, 06:57
SSE SSE Primary ¥
18. 23
+0.72
+4.1119%
¥
16.64B Market Cap
- P/E Ratio
1.24% Div Yield
11.9M Volume
- Eps
¥ 17.51
Previous Close Want to track 603233 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.08 | - |
| | | 0.18 | 0.25 |
| | | 0.24 | 0.3 |
| | | - | - |
| | | 0.32 | 0.35 |
| | | 0.22 | 0.22 |
603233 Earnings Reports FAQ
What is the earnings per share (EPS) for 603233?
EPS data for 603233 is currently not available, as Dashenlin Pharmaceutical Group Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately 13.64%, reflecting the 603233's performance and SSE market conditions.
When is the next earnings release date?
Dashenlin Pharmaceutical Group Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Dashenlin Pharmaceutical Group Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 603233 at this time, as Dashenlin Pharmaceutical Group Co., Ltd has no recent EPS data to calculate it.
